Genetically Altered Mice Harness Benefits of Calorie Restriction

A study identifies a gene that appears to be partially responsible for the health effects of a limited diet.

Written bySophie Fessl, PhD
| 4 min read
illustration of inside of human chest with highlighted gland between the lungs
Register for free to listen to this article
Listen with Speechify
0:00
4:00
Share

Restricting calorie intake extends lifespan and decreases disease burden in animals. In humans, a 14 percent reduction in calorie intake could allow us to harness these beneficial effects, especially on the thymus, a crucial organ for the immune system, according to a study published February 10 in Science. The study also identifies a key protein, PLA2G7, that underlies these effects of calorie restriction, and, the authors say, may point the way toward a means of reaping those benefits with no hunger required.

“By combining human with mice studies, the authors have identified a promising targetable protein. Interfering with this protein can improve metabolic and immune health,” María Mittelbrunn, a researcher in immunometabolism and inflammation at the Severo Ochoa Centre for Molecular Biology in Madrid, Spain, who was not involved in the research, writes in an email to The Scientist. “This study will open a new avenue to investigate whether interfering ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Related Topics

Meet the Author

  • Headshot of Sophie Fessl

    Sophie Fessl is a freelance science journalist. She has a PhD in developmental neurobiology from King’s College London and a degree in biology from the University of Oxford. After completing her PhD, she swapped her favorite neuroscience model, the fruit fly, for pen and paper.

    View Full Profile
Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies